ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Secukinumab mitigates diethyl nitrosamine-induced acute liver injury in mice via modulating p-ERK/p-eIF2α/CHOP and NLRP3/Caspase-1/IL-1β pathways.
Zaid F Al-Rasheedi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.